ArticleBMC psychiatry2025
Network analysis in adolescent patients with somatic symptom disorders.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSomatic symptom disorder (SSD) is one of the most common conditions in adolescents. Persistent symptoms are closely associated with impaired academic performance, reduced social functioning, high healthcare utilization, and increased risk of comorbid psychiatric conditions such as depression, eating disorders, and self-harm. Despite its substantial burden, the clinical mechanisms underlying SSD remain poorly understood, limiting the development of effective, targeted interventions. Clarifying the interrelationships among core somatic symptoms may therefore provide critical insights for clinical management and improve treatment precision.
methodsA total of 585 patients were recruited between June 2024 and January 2025. All participants completed the Chinese versions of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Disorder-B Criteria Scale-12 (SSD-12). To quantify the structure of the somatic symptom network, centrality indices including strength and expected influence were used to identify key symptoms. Bayesian network analysis was further applied to explore potential causal relationships, offering the advantage of directional interpretation within the network framework.
resultsThe symptoms of nausea, dizziness, shortness of breath, and chest pain exhibited the highest centrality values, indicating that they occupied the most central positions within the somatic symptom network. In the Directed Acyclic Graph (DAG), “cannot breathe” is located at the top of the network, indicating its potential directional influences and being more likely to trigger other symptoms.
conclusionWhile the evidence remains inconclusive regarding their direct suitability as treatment targets, psychological and neurobiological research may provide further insights into these central symptoms. Focusing on these nodes could inform future investigations and guide the development of more refined clinical strategies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.